$280 Million Pharmaceutical Manufacturing Joint Venture
Served as lead attorney to a global pharmaceutical company in a manufacturing joint venture valued at more than $280 million, under which the client acquired rights to manufacturing capacity over a term of up to 12 years, with the ability to occupy and purchase the manufacturing facility, with a U.S. subsidiary of a major German pharmaceutical company as manufacturing partner.
